Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-31

FDA Approved: LACOSAMIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original application for lacosamide, enabling a generic lacosamide product to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)